000			01943 a2200529 4500
005			20250516134036.0
264		0	_c20131025
008			201310s 0 0 eng d
022			_a1539-2864
024	7		_a10.1097/IAE.0b013e318271f278 _2doi
040			_aNLM _beng _cNLM
100	1		_aPapavasileiou, Evangelia
245	0	0	_aIntravitreal tissue plasminogen activator, perfluoropropane (C3F8), and ranibizumab or photodynamic therapy for submacular hemorrhage secondary to wet age-related macular degeneration. _h[electronic resource]
260			_bRetina (Philadelphia, Pa.) _cApr 2013
300			_a846-53 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAngiogenesis Inhibitors _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Humanized _xtherapeutic use
650	0	4	_aChoroid Diseases _xdrug therapy
650	0	4	_aCombined Modality Therapy
650	0	4	_aEndotamponade
650	0	4	_aFemale
650	0	4	_aFibrinolytic Agents _xtherapeutic use
650	0	4	_aFluorocarbons _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aIntravitreal Injections
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPhotochemotherapy
650	0	4	_aPolyps _xdrug therapy
650	0	4	_aProne Position
650	0	4	_aRanibizumab
650	0	4	_aRetinal Hemorrhage _xdrug therapy
650	0	4	_aRetrospective Studies
650	0	4	_aTissue Plasminogen Activator _xtherapeutic use
650	0	4	_aTomography, Optical Coherence
650	0	4	_aVisual Acuity _xphysiology
650	0	4	_aWet Macular Degeneration _xcomplications
700	1		_aSteel, David H W
700	1		_aLiazos, Efstathios
700	1		_aMcHugh, Dominic
700	1		_aJackson, Timothy L
773	0		_tRetina (Philadelphia, Pa.) _gvol. 33 _gno. 4 _gp. 846-53
856	4	0	_uhttps://doi.org/10.1097/IAE.0b013e318271f278 _zAvailable from publisher's website
999			_c22495329 _d22495329